The Latest In Oxaloacetate Research
2025 IACFS/ME Virtual Conference Presents Oxalo...
The latest Oxaloacetate CFS clinical trial data will be presented at the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME) 2025 Virtual Research and Medical Conference on October 23, 2025, at...
2025 IACFS/ME Virtual Conference Presents Oxalo...
The latest Oxaloacetate CFS clinical trial data will be presented at the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME) 2025 Virtual Research and Medical Conference on October 23, 2025, at...
New Long COVID Clinical Trial Shows Oxaloacetat...
August 2025 — SAN DIEGO, CA — A new randomized, double-blinded, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for Myalgic...
New Long COVID Clinical Trial Shows Oxaloacetat...
August 2025 — SAN DIEGO, CA — A new randomized, double-blinded, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for Myalgic...
FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...
FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...
International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...
International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...
Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...
Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...
International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...
International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...